European Archives - Page 502 of 1057 - European Medical Journal

Continue
Hematology 9.1 Journal feature image
11 Mins
27 Jul 2021

Review of the European Hematology Association (EHA) 2021 Virtual Congress

THE GLOBAL community of clinicians and researchers shared in the latest advances in haematology care online at the 26th European Hematology Association (EHA) 2021 Virtual Congress.
Hematology 9.1 Journal feature image
July 2021

EMJ Hematology 9.1 2021

Welcome to the latest issue of EMJ Hematology. We are excited to share with you an impressive collection of new and interesting research, alongside our independent review of the European Hematology Association (EHA) 2021 Virtual Congress with the fascinating updates from the event.  
Hematology 9.1 Journal feature image
5 Mins
27 Jul 2021

Diagnosis, Treatment, Impact, and Unmet Needs of People with Mycosis Fungoides and Sézary Syndrome

Mycosis fungoides (MF) and Sézary syndrome (SS), two of the most-studied types of cutaneous T-cell lymphoma (CTCL), account for approximately 60% and 10% of CTCL cases, respectively.
Hematology 9.1 Journal feature image
1 Mins
27 Jul 2021

COVID-19 in Patients with Acute Leukaemia: The Experience of a Haematological Centre

Patients with haematologic malignancies appear to have a greater risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe disease due to myelosuppression.
3 Mins
27 Jul 2021

EULAR Interview: Ruud Delwel

EMJ sits down with Ruud Delwel, Chair of  the Scientific Program Committee, European Hematology Association (EHA) 2021 Virtual Congress.
Interview Image Nikhil Munshi
8 Mins
27 Jul 2021

Interview: Nikhil Munshi

We are talking about 35 years ago, and some of what drew me to the practice is still true today. There were two major aspects of cancer…
Hematology 9.1 Journal feature image
2 Mins
27 Jul 2021

Hepcidin, the Main Regulator of Iron Homeostasis, is a Marker of COVID-19 Severity and Mortality in a Cohort of Hospitalised Italian Patients

Hepcidin, the liver peptide hormone that regulates plasma iron concentration by blocking ferroportin function,4 is at the crossroad between iron metabolism and inflammation, being positively regulated by iron itself and proinflammatory cytokines,5 and may represent the link between iron deficiency and COVID-19 severity.
Hematology 9.1 Journal feature image
10 Mins
27 Jul 2021

Von Willebrand Factor and ADAMTS13 in COVID-19 and Beyond

von Willebrand factor (VWF) is a large, adhesive, multimeric protein involved in haemostasis. The larger the size (or number of VWF multimers), the greater the functionality of the protein.
Hematology 9.1 Journal feature image
2 Mins
27 Jul 2021

Determination of Cut-Off Optimal Values of Ten Haematological Formulas in the Distinction Between Iron Deficiency Anaemia and β-Thalassaemia Minor

Anaemia is a public health problem. Two aetiologies of microcytic anaemia are relatively common in Tunisia: iron deficiency anaemia (IDA)…
EHA-ESMO Guidelines for the Diagnosis, Treatment, and Follow-up of Multiple Myeloma
5 Mins
27 Jul 2021

EHA-ESMO Guidelines for the Diagnosis, Treatment, and Follow-up of Multiple Myeloma

ON DAY 6 of the European Hematology Association (EHA) Virtual Congress 2021, Pieter Sonneveld, Professor of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands, chaired the European Society for Medical Oncology and EHA (ESMO-EHA) joint session on clinical practice guidelines for the diagnosis, treatment, and follow-up of multiple myeloma.